<DOC>
	<DOCNO>NCT00706927</DOCNO>
	<brief_summary>Glaucoma one common cause blindness industrialized nation . For long time glaucoma define disease high intraocular pressure ( IOP ) lead irreversible optic disc damage subsequent visual field loss . However , recent investigation show IOP factor involve glaucomatous process lead retinal ganglion cell death . The role vascular factor pathogenesis glaucoma recently receive much attention base animal experiment epidemiological study . The main focus glaucoma still direct towards decrease IOP . There , however , also considerable interest whether antiglaucoma drug influence ocular perfusion . Although measurement ocular blood flow still difficult , number innovative technique realize cover different aspect ocular perfusion . In present study Xalacom® ( latanoprost/timolol ) fix combination Combigan® ( brimonidine/timolol ) compare respect IOP lower efficacy well ocular hemodynamic effect .</brief_summary>
	<brief_title>Effect Xalacom® ( Latanoprost/Timolol ) Combigan® ( Brimonidine/Timolol ) Fixed Combination Intraocular Pressure Ocular Blood Flow Patients With Primary Open Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<criteria>Men woman 18 year Unilateral bilateral primary open angle glaucoma , ocular hypertension , exfoliation glaucoma , pigmentary glaucoma IOP 22 35mmHg At least 3 reliable visual field testing 4 week ß adrenergic receptor antagonist prostaglandin analogue , 2 week adrenergic agonist , 5 day cholinergic agonist carbonic anhydrase inhibitor History acute angle closure Closed barely open anterior chamber angle Mean deviation visual field test &gt; 10 Intraocular surgery argon laser trabeculoplasty within last six month Ocular inflammation infection within last three month Contact lenses Patients bradycardia ( heart rate &lt; 50 beats/min ) Second third degree heart block Asthma COPD Congestive heart failure Severe renal impairment ( creatinine clearance &lt; 1.8 L/h ) History hypersensitivity one study drug drug similar chemical structure Topical systematically/oral therapy steroid History nonIOP responder betablockers , alpha2 adrenergic prostaglandin analogue Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>xalacom</keyword>
	<keyword>combigan</keyword>
	<keyword>ocular blood flow</keyword>
</DOC>